The AHA Feb. 28 filed a friend-of-the-court brief ( in the U.S. District Court for the District of Columbia, urging the court ...

The AHA Feb. 28 filed a friend-of-the-court brief in the U.S. Court of Appeals for the 4th Circuit, urging the court to ...

The industry could see payment, workforce and insurance coverage changes depending on how the Trump administration weighs in ...

In just 10 years, annual 340B purchases grew more than 700%, from $7.5 billion in 2013 to $53.7 billion in 2022. Factors underlying this growth include. Exponential growth in participation by non ...

Eli Lilly, Bristol Myers Squibb, Sanofi and Novartis are seeking to block a major hospital trade group from intervening in ...

The 340B program, intended to lower drug costs for low-income patients, often benefits hospitals more than patients. A lack of transparency allows some hospitals to profit from the program instead ...

after the regulator rejected their plans to change how they offer 340B discounts. In December, Sanofi and Bristol Myers Squibb followed suit. The discount program designed to keep safety-net ...